Sol-Gel Technologies Ltd.
SLGL
$76.22
-$3.78-4.73%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/5/2026
-
The Cerbat Gem
6/3/2026
-
Tickeron - Stocks
5/29/2026
-
Tickeron - Stocks
5/29/2026
-
Simply Wall St
5/28/2026
-
Zacks Investment Research
5/28/2026
-
TipRanks Financial Blog
5/28/2026
-
Globe Newswire
5/27/2026
-
Tickeron - Stocks
5/23/2026
-
Tickeron - Stocks
5/23/2026
-
Tickeron - Stocks
5/23/2026
-
Tickeron - Stocks
5/22/2026
-
Tickeron - Stocks
Sol-Gel Technologies (SLGL, $63.31) price may climb as it broke lower Bollinger Band on May 19, 2026
5/20/2026
-
Tickeron - Stocks
5/20/2026
-
Tickeron - Stocks
5/20/2026
-
Tickeron - Stocks
5/16/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/14/2026
-
The Cerbat Gem
5/14/2026
-
Tickeron - Stocks
5/6/2026
-
Tickeron - Stocks
5/2/2026
-
Tickeron - Stocks
5/2/2026
-
Tickeron - Stocks
5/1/2026
-
Tickeron - Stocks
5/1/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, March 19, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 8 931 3433
Address
7 Golda Meir Street
Ness Ziona, 7403650
Ness Ziona, 7403650
Country
Year Founded
Business Description
Sector
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland...
more